Maria Fernanda Ortiz‐Nuño
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Fernanda Ortiz‐Nuño has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Jesus Alberto Cardenas-De la Garza
Rheumatology Department, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México
6 shared publications - Dionicio Angel Galarza-Delgado
Rheumatology Department, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México
4 shared publications - Gisela Garcia-Arellano
Rheumatology Department, Universidad Autónoma de Nuevo León, Hospital Universitario “Dr. José Eleuterio González”, Monterrey, México
3 shared publications - Griselda Serna-Peña
Rheumatology Department, Universidad Autónoma de Nuevo León, Hospital Universitario “Dr. José Eleuterio González”, Monterrey, México
3 shared publications - Juan Pablo Toledo-Motta
Rheumatology Department Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León Monterrey Mexico
2 shared publications - Alexandro Bonifaz
Department of Dermatology, General Hospital of Mexico, Mexico City, Mexico
1 shared publication
Latest Publications
- 9 March 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (3) , e70601
Outpatient Non‐Attendance in Rheumatology Consult and Its Relationship With Depression and Anxiety
- 9 March 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (3) , e70601
Outpatient Non‐Attendance in Rheumatology Consult and Its Relationship With Depression and Anxiety
- 7 November 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (4) , 884-887
Alopecia Areata Associated With Bimekizumab Therapy
- 7 November 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (4) , 884-887
Alopecia Areata Associated With Bimekizumab Therapy
- 23 October 2025
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 45 (2) , 303-314
Cutaneous botryomycosis: a comprehensive review
Purpose Cutaneous botryomycosis is a chronic, granulomatous infection of the skin caused by different bacteria that form granular aggregates. We aim to provide a complete, comprehensive, and updated review of cutaneous botryomycosis, including a review of cases published in the last decade. Results Patients with botryomycosis typically present multiple nodules, sinuses, abscesses, fistulae, and ulcers, which develop during weeks or months. The current gold standard for diagnosing botryomycosis involves a combination of histopathological examination and microbial culture. A definitive diagnosis is established when clinical and pathological findings align with the presence of botryomycosis, supported by the identification of non-filamentous bacteria forming granules and positive culture. The most frequent isolated etiological agents are Staphylococcus aureus followed by Pseudomonas aeruginosa. The differential diagnosis includes mycetoma, actinomycosis, and carcinomas/sarcomas. Treatment includes antibiotics and, in selected cases, surgical debridement.
- 23 October 2025
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 45 (2) , 303-314
Cutaneous botryomycosis: a comprehensive review
Purpose Cutaneous botryomycosis is a chronic, granulomatous infection of the skin caused by different bacteria that form granular aggregates. We aim to provide a complete, comprehensive, and updated review of cutaneous botryomycosis, including a review of cases published in the last decade. Results Patients with botryomycosis typically present multiple nodules, sinuses, abscesses, fistulae, and ulcers, which develop during weeks or months. The current gold standard for diagnosing botryomycosis involves a combination of histopathological examination and microbial culture. A definitive diagnosis is established when clinical and pathological findings align with the presence of botryomycosis, supported by the identification of non-filamentous bacteria forming granules and positive culture. The most frequent isolated etiological agents are Staphylococcus aureus followed by Pseudomonas aeruginosa. The differential diagnosis includes mycetoma, actinomycosis, and carcinomas/sarcomas. Treatment includes antibiotics and, in selected cases, surgical debridement.
- 17 January 2025
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 28 (1) , e70077
Correlations Between Neutrophil/Lymphocyte Ratio, Platelets/Lymphocyte Ratio, and Systemic Immune‐Inflammation Index and Fatigue in Systemic Lupus Erythematosus
- 17 January 2025
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 28 (1) , e70077
Correlations Between Neutrophil/Lymphocyte Ratio, Platelets/Lymphocyte Ratio, and Systemic Immune‐Inflammation Index and Fatigue in Systemic Lupus Erythematosus
- 6 June 2024
- Published by SAGE Publications in Lupus
- Vol. 33 (9) , 979-985
Impact of intimate partner violence on quality of life and disease activity in women with systemic lupus erythematosus
Objective: Stress and trauma are psychosocial factors with an impact on the course of systemic lupus erythematosus (SLE). The influence of violence on SLE has not been entirely explored, even though women (including patients with rheumatic diseases) are a vulnerable population to any form of violence. This study aims to assess the prevalence and impact of intimate partner violence (IPV) on health-related quality of life in women with SLE. Methods: An observational, cross-sectional, and analytical study was conducted at a rheumatology clinic of a university hospital from September 2022 and September 2023. We evaluated the presence of IPV in 85 women with SLE with the Hurt, Insulted, Threatened with Harm and Screamed at (HITS) questionnaire and the Index of Spouse Abuse (ISA), and quality of life with LupusQoL. Results: The prevalence by HITS score of past-year IPV was 24.4% and of lifetime IPV was 36.5%. Past-year non-physical violence was present in 17.1% of patients by ISA, and 27.1% were victims in their lifetime. While in physical violence, 7.3% were victims in the previous year and 21.2% in their lifetime. The total quality of life and the emotional domain by LupusQoL were diminished in victims of past-year IPV, compared to those who weren’t exposed ( p = .018 and p = .036, respectively). Past-year HITS score correlated with the Physician Global Assessment (PGA) (rho = 0.301, p = .006), while lifetime HITS score correlated with PGA (rho = 0.329, p = .002) and SLEDAI-2K (rho = 0.277, p = .010). Conclusion: We found that one in four women suffered IPV in the previous year, and those who were exposed had diminished quality of life. Also, the severity of the abuse correlated with disease activity. Our findings emphasize the importance of comprehensive care for patients with SLE.
- 6 June 2024
- Published by SAGE Publications in Lupus
- Vol. 33 (9) , 979-985
Impact of intimate partner violence on quality of life and disease activity in women with systemic lupus erythematosus
Objective: Stress and trauma are psychosocial factors with an impact on the course of systemic lupus erythematosus (SLE). The influence of violence on SLE has not been entirely explored, even though women (including patients with rheumatic diseases) are a vulnerable population to any form of violence. This study aims to assess the prevalence and impact of intimate partner violence (IPV) on health-related quality of life in women with SLE. Methods: An observational, cross-sectional, and analytical study was conducted at a rheumatology clinic of a university hospital from September 2022 and September 2023. We evaluated the presence of IPV in 85 women with SLE with the Hurt, Insulted, Threatened with Harm and Screamed at (HITS) questionnaire and the Index of Spouse Abuse (ISA), and quality of life with LupusQoL. Results: The prevalence by HITS score of past-year IPV was 24.4% and of lifetime IPV was 36.5%. Past-year non-physical violence was present in 17.1% of patients by ISA, and 27.1% were victims in their lifetime. While in physical violence, 7.3% were victims in the previous year and 21.2% in their lifetime. The total quality of life and the emotional domain by LupusQoL were diminished in victims of past-year IPV, compared to those who weren’t exposed ( p = .018 and p = .036, respectively). Past-year HITS score correlated with the Physician Global Assessment (PGA) (rho = 0.301, p = .006), while lifetime HITS score correlated with PGA (rho = 0.329, p = .002) and SLEDAI-2K (rho = 0.277, p = .010). Conclusion: We found that one in four women suffered IPV in the previous year, and those who were exposed had diminished quality of life. Also, the severity of the abuse correlated with disease activity. Our findings emphasize the importance of comprehensive care for patients with SLE.
- 14 May 2024
- Published by Wiley in Arthritis & Rheumatology
- Vol. 76 (9) , 1457-1458
Clinical Images: Burton line and scar hyperpigmentation in a patient with severe lead poisoning and saturnine gout
- 14 May 2024
- Published by Wiley in Arthritis & Rheumatology
- Vol. 76 (9) , 1457-1458
Clinical Images: Burton line and scar hyperpigmentation in a patient with severe lead poisoning and saturnine gout